Kirklin/Barratt-Boyes Cardiac Surgery: 2-Volume Set
0443075263
9780443075261
Description:
The definitive textbook in both adult and pediatric cardiac surgery is back--updated and revised in a new, 3rd Edition! It thoroughly covers the full range of new and classic surgical procedures and presents the up-to-date clinical evidence practitioners need to make effective management decisions.
- Covers ischemic, valvular, and congenital heart disease; cardiac tumors; constrictive pericarditis; thoracic aortic surgery; cardiac transplantation; and much more.
- Explores each condition's natural history, diagnostic criteria, indications for surgery, operative techniques, and follow-up care.
- Features brand-new chapters covering diseases of the pulmonary arteries and diseases of the systemic veins, including Infective Endocarditis (Ch. 15).
- Incorporates significant updates on coronary artery disease, aortic valve disease, cardiac rhythm disturbances, heart failure and transplantation, disease of the thoracic aorta, tetralogy of Fallot, anesthesia, and postoperative care.
- Presents thousands of up-to-date references.
- Features hundreds of new procedural illustrations.
Best prices to buy, sell, or rent ISBN 9780443075261
Frequently Asked Questions about Kirklin/Barratt-Boyes Cardiac Surgery: 2-Volume Set
The price for the book starts from $71.46 on Amazon and is available from 9 sellers at the moment.
If you’re interested in selling back the Kirklin/Barratt-Boyes Cardiac Surgery: 2-Volume Set book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Kirklin/Barratt-Boyes Cardiac Surgery: 2-Volume Set book, the best buyback offer comes from and is $ for the book in good condition.
The Kirklin/Barratt-Boyes Cardiac Surgery: 2-Volume Set book is in very low demand now as the rank for the book is 8,137,102 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.